However, Gokulnath et al. described that ATF3 is efficiently recruited onto RUNX2 promoter and stimulates its transcription in bone metastatic breast cancer cells, indicating that RUNX2 is a direct downstream target gene of ATF3 [153]. The gene discussed is RUNX2; the disease is breast cancer.